FDA Approves First Subcutaneous Apomorphine Device for Parkinson Disease
The FDA has approved apomorphine hydrochloride injection (Onapgo), the first and only subcutaneous apomorphine infusion device for the treatment of advanced Parkinson disease. The product, developed by Supernus Pharmaceuticals and formally known as SPN-830 …